These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 1244776)

  • 21. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
    Nelson TE; Flewellen EH
    Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
    Gallant EM; Fletcher TF; Goettl VM; Rempel WE
    Muscle Nerve; 1986 Feb; 9(2):174-84. PubMed ID: 3951491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
    Foster PS; Hopkinson KC; Denborough MA
    Clin Exp Pharmacol Physiol; 1989 Oct; 16(10):799-805. PubMed ID: 2612062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dantrolene sodium on the efflux of Ca45 from rat heavy sarcoplasmic reticulum.
    Francis KT
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):573-6. PubMed ID: 705031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome].
    López JR; Alamo LA; Jones D; Papp L; Allen P; Gergely J; Streter F
    Acta Cient Venez; 1985; 36(1):102-4. PubMed ID: 4090898
    [No Abstract]   [Full Text] [Related]  

  • 28. Site of action of dantrolene in frog sartorius muscle.
    Putney JW; Biancri CP
    J Pharmacol Exp Ther; 1974 Apr; 189(1):202-12. PubMed ID: 4545054
    [No Abstract]   [Full Text] [Related]  

  • 29. Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine.
    López JR; Allen PD; Alamo L; Jones D; Sreter FA
    Muscle Nerve; 1988 Jan; 11(1):82-8. PubMed ID: 3340102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
    Gallant EM; Godt RE; Gronert GA
    J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium-induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. The effects of halothane and dantrolene.
    Ohnishi ST; Taylor S; Gronert GA
    FEBS Lett; 1983 Sep; 161(1):103-7. PubMed ID: 6884519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs.
    Ohnishi ST; Waring AJ; Fang SR; Horiuchi K; Flick JL; Sadanaga KK; Ohnishi T
    Arch Biochem Biophys; 1986 Jun; 247(2):294-301. PubMed ID: 2424370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
    Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses.
    Nelson TE
    Anesthesiology; 1990 Sep; 73(3):449-54. PubMed ID: 2393129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. W-7, a calmodulin antagonist, and contracture of malignant hyperthermia susceptible skeletal muscle.
    Holland M; Williams JH; Lee JC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Feb; 101(2):383-8. PubMed ID: 1354116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia in dogs.
    Nelson TE
    J Am Vet Med Assoc; 1991 Mar; 198(6):989-94. PubMed ID: 2032926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers.
    Williams JH; Holland M; Lee JC; Ward CW; McGrath CJ
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R782-6. PubMed ID: 1718170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.
    Nelson TE; Denborough MA
    Clin Exp Pharmacol Physiol; 1977; 4(3):315-22. PubMed ID: 891045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle.
    Ohta T; Endo M; Nakano T; Morohoshi Y; Wanikawa K; Ohga A
    Am J Physiol; 1989 Feb; 256(2 Pt 1):C358-67. PubMed ID: 2919663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.